These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 4260406)
21. The relevance of the structure of lysine bound to Sepharose for the affinity of rabbit plasminogen; Hatton MW; Regoeczi E Biochim Biophys Acta; 1975 Feb; 379(2):504-11. PubMed ID: 1122301 [TBL] [Abstract][Full Text] [Related]
22. Human plasminogen: a summary of studies on its isolation, characterization and activation mechanism. Rickli EE Immunochemistry; 1975 Jul; 12(6-7):629-32. PubMed ID: 126948 [No Abstract] [Full Text] [Related]
23. Generation of 125 I-labelled plasmin in dogs in response to venous injury. Takeda Y; Parkhill TR; Nakabayashi M Ciba Found Symp; 1972; 9():203-16. PubMed ID: 4266977 [No Abstract] [Full Text] [Related]
24. High-performance affinity chromatography of plasmin and plasminogen on a hydrophilic vinyl-polymer gel coupled with p-aminobenzamidine. Shimura K; Kazama M; Kasai K J Chromatogr; 1984 Jun; 292(2):369-82. PubMed ID: 6235238 [TBL] [Abstract][Full Text] [Related]
25. Factors influencing the separation of glu-plasminogen affinity forms I and II by affinity chromatography. Traas DW; Hoegee-de Nobel B; Nieuwenhuizen W Thromb Haemost; 1984 Dec; 52(3):347-9. PubMed ID: 6531758 [TBL] [Abstract][Full Text] [Related]
27. Photoaffinity labeling of human plasmin and plasminogen. Ryan TJ Pharmacol Ther; 1987; 34(2):335-48. PubMed ID: 2960990 [No Abstract] [Full Text] [Related]
28. Human plasminogen: in vitro and in vivo evidence for the biological integrity of NH2-terminal glutamic acid plasminogen. Collen D; Ong EB; Johnson AJ Thromb Res; 1975 Oct; 7(4):515-29. PubMed ID: 1081757 [No Abstract] [Full Text] [Related]
29. Immobilized human plasmins: preparation and enzymatic properties. Chibber BA; Leadbetter MG; Mertz ET Prep Biochem; 1974; 4(4):315-30. PubMed ID: 4280068 [No Abstract] [Full Text] [Related]
30. Carbohydrate of the human plasminogen variants. I. Carbohydrate composition, glycopeptide isolation, and characterization. Hayes ML; Castellino JF J Biol Chem; 1979 Sep; 254(18):8768-71. PubMed ID: 479156 [No Abstract] [Full Text] [Related]
31. Preparation of human immunoglobulin free of plasmin and anticomplement activities. Habeeb AF; Francis RD Vox Sang; 1977; 32(3):143-58. PubMed ID: 140530 [TBL] [Abstract][Full Text] [Related]
32. A sensitive fluorometric assay for plasminogen, plasmin, and streptokinase. Bell PH; Dziobkowski CT; Englert ME Anal Biochem; 1974 Sep; 61(1):200-8. PubMed ID: 4277983 [No Abstract] [Full Text] [Related]
33. Characterization of human plasminogen. II. Separation and partial characterization of different molecular forms of human plasminogen. Wallén P; Wiman B Biochim Biophys Acta; 1972 Jan; 257(1):122-34. PubMed ID: 4257942 [No Abstract] [Full Text] [Related]
34. Plasminogen activator formed by reaction of streptokinase with human plasminogen. Ts'ao CH; Kline DL J Appl Physiol; 1969 May; 26(5):634-9. PubMed ID: 4238461 [No Abstract] [Full Text] [Related]
35. Studies on plasminogen. VII. Mechanism of activation of bovine plasminogen. Hoepfinger LM; Mertz ET Can J Biochem; 1969 Oct; 47(10):909-15. PubMed ID: 4242505 [No Abstract] [Full Text] [Related]